Abstract
Background
The evolution of sentinel node biopsy has placed new emphasis on the biology of lymphatic metastases in breast cancer. If radiocolloid mimics the migration of tumor cells, the nodes with the most uptake should also be the most likely to harbor metastatic cells. We attempted to correlate the frequency of metastatic disease to the greatest gamma uptake and to clarify the physiology of breast lymphatic drainage.
Methods
Data were collected from 152 patients undergoing sentinel node biopsy from January 1997 to June 1999. Localization was by injection of unfiltered99mTc-labeled sulfur colloid. Sentinel nodes were identified with an intraoperative gamma counter and the 10% rule. A completion level I/II axillary dissection was performed in all patients.
Results
Fifty-four of 152 patients were positive for metastatic disease. There were no falsenegative sentinel nodes. In 46 (85%) of 54 cases, the node with the highest uptake was positive for metastatic disease. In the remaining eight (15%) cases, another node with a lower gamma count was positive.
Conclusions
The sentinel node with the highest uptake is not the one that contains metastatic disease in 15% of cases. This may reflect variations in lymphatic channels or technical variations in colloid properties and injection technique.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Krag DN, Weaver DL, Alex JC, Fairbank JT. Surgical resection and radiolocalization of the sentinel node in breast cancer using gamma probe.Surg Oncol 1993;2:335–40.
Boolbol SK, Fey JV, Borgen PI, et al. Intradermal isotope injection: a highly accurate method of lymphatic mapping in breast carcinoma.Ann Surg Oncol 2001;8:20–4.
Linehan DC, Hill AD, Akhurst T, et al. Intradermal radiocolloid and intraparenchymal blue dye injection optimize sentinel node identification in breast cancer patients.Ann Surg Oncol 1999;6:450–4.
Krag D, Weaver D, Takamaru A, et al. The sentinel node in breast cancer.N Engl J Med 1998;339:941–6.
Martin RCG, Edwards MJ, Wong SL, et al. Practical guidelines for optimal gamma probe detection of sentinel lymph nodes in breast cancer: results of a multi-institutional study.Surgery 2000;128:139–44.
Albertini JJ, Lyman GH, Cox C, et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer.JAMA 1996;276:1818–22.
Kern KA, Rosenberg RJ. Preoperative lymphoscintigraphy during lymphatic mapping for breast carcinoma: improved sentinel node imaging using subareolar injection of technetium 99m sulfur colloid.J Am Coll Surg 2000;191:479–89.
Martin RCG, Fey J, Yeung H, Borgen PI, Cody HS. Highest isotope count does not predict sentinel node positivity in all breast cancer patients.Ann Surg Oncol 2001;8:592–7.
Tanis PJ, Nieweg OE, Valdes Olmos RA, Kroon BBR. Anatomy and physiology of lymphatic drainage of the breast from the perspective of sentinel node biopsy.J Am Coll Surg 2001;192:399–409.
Krag DN. Nimmal access surgery for staging regional lymph nodes: the sentinel-node concept.Curr Probl Surg 1998;35:951–1016.
Boxen I, McCready DR, Ballinger JR. Sentinel node detection and definition may depend on the imaging agent and timing.Clin Nucl Med 1992;24:390–4.
Olszewski WL, Engset A. Lymphatic contractions.N Engl J Med 1979;300:316.
Ludwig J. Ueber Kurschlusswege der Lymphbahnen und ihre Beziewhungen zur lymphogen Krebsmetastasierung.Pathol Microbiol 1962;25:329–34.
Derossis AM, Fey J, Yeung H, et al. A trend analysis of the relative value of blue dye and isotope localization in 2,000 consecutive cases of sentinel node biopsy for breast cancer.J Am Coll Surg 2001;193:473–8.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Quan, M.L., McCready, D., Temple, W.J. et al. Biology of lymphatic metastases in breast cancer: Lessons learned from sentinel node biopsy. Annals of Surgical Oncology 9, 467–471 (2002). https://doi.org/10.1007/BF02557270
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02557270